GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Gross Margin (2009 - 2026)

Updated

Gsk's Gross Margin was 73.11% in the quarter ended Sep 30, 2026, down 0.47 percentage points from 73.58% a year earlier but up 0.05 percentage points from the prior quarter.

Analysis

Gsk (GSK) Gross Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Gsk's Gross Margin was 73.01% through Sep 30, 2026, up 0.72 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 72.40%, up 1.23 percentage points from the prior year.

  • Gross Margin shows a five-year change of +4.95 percentage points (years ended Dec 2020 to Dec 2025).
  • In earlier years, Gross Margin was 71.16% in the year ended Dec 31, 2024 (-0.60 pp), 71.76% in the year ended Dec 31, 2023 (+4.34 pp), 67.42% in the year ended Dec 31, 2022 (+0.47 pp) and 66.95% in the year ended Dec 31, 2021 (-0.50 pp).
  • Quarterly Gross Margin has moved between 60.64% (the quarter ended Dec 31, 2021) and 75.42% (the quarter ended Mar 31, 2026) over five years.
  • Compared with a year earlier, Gross Margin was higher in five of the last eight quarters, with an average year-over-year change of +0.95 percentage points.
  • The best year-over-year quarter for Gross Margin over five years was the quarter ended Mar 31, 2023 (a gain of 9.84 percentage points); the worst was the quarter ended Mar 31, 2022 (a drop of 5.70 percentage points).
  • Per Business Quant data, GSK's Gross Margin in the three quarters before the quarter ended Sep 30, 2026 was 73.05% (quarter ended Jun 30, 2026), 75.42% (quarter ended Mar 31, 2026) and 72.40% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 68.12%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 75.38%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 72.95%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 88.03%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 73.10%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 81.07%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 75.71%
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn 73.11%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 73.11%
Jun 30, 2026 73.05%
Mar 31, 2026 75.42%
Dec 31, 2025 72.40%
Sep 30, 2025 73.58%
Jun 30, 2025 72.89%
Mar 31, 2025 74.23%
Dec 31, 2024 68.47%
Sep 30, 2024 70.08%
Jun 30, 2024 73.08%
Mar 31, 2024 73.24%
Dec 31, 2023 69.97%
Sep 30, 2023 72.11%
Jun 30, 2023 73.08%
Mar 31, 2023 72.05%
Dec 31, 2022 69.66%
Sep 30, 2022 69.05%
Jun 30, 2022 68.60%
Mar 31, 2022 62.21%
Dec 31, 2021 60.64%
API Access

Gsk Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY